Document is current
Any future updates will be listed below
-
Authors
Vogt, Melina
Dienstbier, Niklas https://orcid.org/0009-0000-0871-9165
Schliehe-Diecks, Julian
Scharov, Katerina
Tu, Jia-Wey
Gebing, Philip
Hogenkamp, Julian
Bilen, Berna-Selin
Furlan, Silke
Picard, Daniel https://orcid.org/0000-0003-3375-6202
Remke, Marc https://orcid.org/0000-0002-9404-9993
Yasin, Layal
Bickel, David https://orcid.org/0000-0003-0332-8338
Kalia, Munishikha
Iacoangeli, Alfredo https://orcid.org/0000-0002-5280-5017
Lenz, Thomas https://orcid.org/0000-0002-4799-5549
Stühler, Kai
Pandyra, Aleksandra A.
Hauer, Julia
Fischer, Ute https://orcid.org/0000-0002-2455-2489
Wagener, Rabea
Borkhardt, Arndt https://orcid.org/0000-0002-6121-4737
Bhatia, Sanil https://orcid.org/0000-0001-6494-7744
- License Information
-
More Information
Article History
Received: 6 June 2023
Revised: 22 November 2023
Accepted: 23 November 2023
First Online: 6 December 2023
Competing interests
: The authors declare no competing interests.
: All animal experiments were conducted in accordance with the regulatory guidelines of the official committee at LANUV (Akt. 81-02.04.2017.A441), under the authorization of the animal research institute (ZETT) at the Heinrich Heine University Düsseldorf. In house leukemia cells derived from the peripheral blood (PB) or bone marrow (BM) of three relapsed (TKI-resistant) patients after obtaining informed consent in accordance with the Declaration of Helsinki. The experiments were approved by the ethics committee of the medical faculty of the Heinrich Heine University (Study Nr.: 2019-566).
